Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial (Q74265787)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

P J Mease

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B S Goffe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Metz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A VanderStoep

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Finck

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D J Burge

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

9227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

385-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

cites work

Treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Methotrexate in psoriasis: consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Cyclosporine consensus conference: with emphasis on the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

1 reference

7 January 2021

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Mortality studies in psoriatic arthritis. Results from a single outpatient clinic. I. Causes and risk of death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Psoriatic arthritis: a quantitative overview of therapeutic options. The Psoriatic Arthritis Meta-Analysis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Methotrexate use in psoriasis and psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902530-7

7 January 2021

10.1016/S0140-6736(00)02530-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972371%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference